We are live on ! Find out more
NBP icon

NovaBridge Biosciences American Depositary Shares

57 hedge funds and large institutions have $132M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

90% more capital inflows, than outflows

Capital inflows: $38.6M | Capital outflows: $20.4M

36% more funds holding

Funds holding: 42 → 57 (+15)

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

3.04% more ownership

Funds ownership: 25.76% → 28.8% (+3%)

23% less call options, than puts

Call options by funds: $277K | Put options by funds: $359K

Holders
57
Holders Change
+15
Holders Change %
+35.71%
% of All Funds
0.69%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
21
Increased
16
Reduced
12
Closed
5
Calls
$277​K
Puts
$359​K
Net Calls
-⁠$82​K
Net Calls Change
-⁠$154​K

NBP Hedge Fund Activity: Q4 2025 in Review

57 of the 8,319 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2025, worth a combined $132M — up 18% from $112M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NBP positions and 5 closed out — a net gain of 16 holders — while 16 added to existing stakes and 12 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $9.8M. The largest seller was Adage Capital Partners, cutting an estimated $10.3M.

  • 57 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2025, up from 42 in Q3 2025.
  • Funds reported $132M of NovaBridge Biosciences American Depositary Shares stock for Q4 2025, up 18% quarter-over-quarter.
  • 21 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2025 and 5 closed out, a net change of +16 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2025 was Point72 Asset Management, an estimated $9.8M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2025 was Adage Capital Partners, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2025.